ZA897020B - Derivatives of human/bovine basic fibroblast growth factor - Google Patents
Derivatives of human/bovine basic fibroblast growth factorInfo
- Publication number
- ZA897020B ZA897020B ZA897020A ZA897020A ZA897020B ZA 897020 B ZA897020 B ZA 897020B ZA 897020 A ZA897020 A ZA 897020A ZA 897020 A ZA897020 A ZA 897020A ZA 897020 B ZA897020 B ZA 897020B
- Authority
- ZA
- South Africa
- Prior art keywords
- derivatives
- human
- bfgf
- growth factor
- fibroblast growth
- Prior art date
Links
- 101001051969 Bos taurus Fibroblast growth factor 2 Proteins 0.000 title abstract 2
- 101001052035 Homo sapiens Fibroblast growth factor 2 Proteins 0.000 title abstract 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 abstract 4
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 2
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 108020004511 Recombinant DNA Proteins 0.000 abstract 1
- 230000002491 angiogenic effect Effects 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 230000002483 superagonistic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Eye Examination Apparatus (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888821795A GB8821795D0 (en) | 1988-09-16 | 1988-09-16 | New derivatives of human/bovine basic fibroplast growth factor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA897020B true ZA897020B (en) | 1990-08-29 |
Family
ID=10643728
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA897020A ZA897020B (en) | 1988-09-16 | 1989-09-14 | Derivatives of human/bovine basic fibroblast growth factor |
Country Status (21)
| Country | Link |
|---|---|
| EP (2) | EP0363675B1 (xx) |
| JP (1) | JP2888575B2 (xx) |
| KR (1) | KR900702027A (xx) |
| CN (1) | CN1041181A (xx) |
| AT (1) | ATE98693T1 (xx) |
| AU (1) | AU620925B2 (xx) |
| CA (1) | CA1340834C (xx) |
| DE (1) | DE68911461T2 (xx) |
| DK (1) | DK120290A (xx) |
| ES (1) | ES2061855T3 (xx) |
| FI (1) | FI902391A0 (xx) |
| GB (1) | GB8821795D0 (xx) |
| HU (1) | HUT53937A (xx) |
| IL (1) | IL91615A0 (xx) |
| MY (1) | MY104910A (xx) |
| NO (1) | NO902176L (xx) |
| NZ (1) | NZ230621A (xx) |
| PT (1) | PT91719B (xx) |
| WO (1) | WO1990002800A1 (xx) |
| YU (1) | YU179489A (xx) |
| ZA (1) | ZA897020B (xx) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5143829A (en) * | 1990-03-29 | 1992-09-01 | California Biotechnology Inc. | High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
| US5478804A (en) * | 1990-09-19 | 1995-12-26 | The Salk Institute For Biological Studies | Treatment of tumorigenic pathophysiological conditions with FGF-cytoxic conjugates |
| US6833354B1 (en) | 1990-12-19 | 2004-12-21 | Kaken Pharmaceutical Co., Ltd. | Agent for the treatment of bone diseases |
| JP3135138B2 (ja) * | 1990-12-19 | 2001-02-13 | 科研製薬株式会社 | 骨疾患治療剤 |
| DE69205466T2 (de) * | 1991-03-21 | 1996-05-30 | Procter & Gamble | Mittel zur Kontrolle von Hautfalten, die die Arg-Ser-Arg-Lys-Sequenzen enthalten. |
| JP3303211B2 (ja) * | 1991-04-26 | 2002-07-15 | 武田薬品工業株式会社 | ｂＦＧＦムテインおよびその製造法 |
| TW275068B (xx) * | 1993-09-24 | 1996-05-01 | American Cyanamid Co | |
| AUPO247496A0 (en) | 1996-09-23 | 1996-10-17 | Resmed Limited | Assisted ventilation to match patient respiratory need |
| US6214795B1 (en) * | 1996-11-12 | 2001-04-10 | Praecis Pharmaceuticals, Inc. | Peptide compounds useful for modulating FGF receptor activity |
| US6274712B1 (en) | 1997-12-23 | 2001-08-14 | 3-Dimensional Pharmaceuticals, Inc. | Analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamute 89, aspartate 101 or leucine 137 |
| FR2780416B1 (fr) * | 1998-06-10 | 2002-12-20 | Rhone Poulenc Nutrition Animal | Procede industriel de production de proteines heterologues chez e. coli et souches utiles pour le procede |
| EP1207900A2 (en) * | 1999-08-13 | 2002-05-29 | Chiron Corporation | Dose of an angiogenic factor and method of administering to improve myocardial blood flow |
| DE69933057T2 (de) * | 1999-12-22 | 2007-03-15 | Ortho-Mcneil Pharmaceutical, Inc. | Analoge des humanen basischen fibroblasten-wachstumsfactors |
| CA2430112C (en) | 2000-11-27 | 2010-07-27 | Dnavec Research Inc. | Paramyxovirus vector encoding angiogenesis gene and use thereof |
| WO2013090919A1 (en) * | 2011-12-16 | 2013-06-20 | Wisconsin Alumni Research Foundation | Fgf-2 having enhanced stability |
| CN106957359B (zh) * | 2016-08-31 | 2020-04-24 | 黄志锋 | Fgf1突变体及其医药应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL81839A0 (en) * | 1986-03-14 | 1987-10-20 | Takeda Chemical Industries Ltd | Polypeptide,dna and its use |
| AU1185488A (en) * | 1987-01-16 | 1988-08-10 | Amgen, Inc. | Production of fibroblast growth factor |
| JP2526965B2 (ja) * | 1987-02-24 | 1996-08-21 | 武田薬品工業株式会社 | ムテイン，ｄｎａおよびその用途 |
| JP2879148B2 (ja) * | 1987-07-07 | 1999-04-05 | サイオス インコーポレイテッド | 組換え繊維芽細胞成長因子 |
| EP0326907A1 (en) * | 1988-01-26 | 1989-08-09 | Takeda Chemical Industries, Ltd. | Polypeptide, DNA and its use |
-
1988
- 1988-09-16 GB GB888821795A patent/GB8821795D0/en active Pending
-
1989
- 1989-09-12 NZ NZ230621A patent/NZ230621A/en unknown
- 1989-09-12 IL IL91615A patent/IL91615A0/xx unknown
- 1989-09-14 ZA ZA897020A patent/ZA897020B/xx unknown
- 1989-09-14 CN CN89107069A patent/CN1041181A/zh active Pending
- 1989-09-14 MY MYPI89001258A patent/MY104910A/en unknown
- 1989-09-14 CA CA000611335A patent/CA1340834C/en not_active Expired - Fee Related
- 1989-09-14 PT PT91719A patent/PT91719B/pt not_active IP Right Cessation
- 1989-09-15 YU YU01794/89A patent/YU179489A/xx unknown
- 1989-09-15 EP EP89117112A patent/EP0363675B1/en not_active Expired - Lifetime
- 1989-09-15 WO PCT/EP1989/001075 patent/WO1990002800A1/en not_active Application Discontinuation
- 1989-09-15 EP EP89910440A patent/EP0396664A1/en active Pending
- 1989-09-15 DE DE68911461T patent/DE68911461T2/de not_active Expired - Fee Related
- 1989-09-15 AU AU43171/89A patent/AU620925B2/en not_active Ceased
- 1989-09-15 ES ES89117112T patent/ES2061855T3/es not_active Expired - Lifetime
- 1989-09-15 JP JP1509755A patent/JP2888575B2/ja not_active Expired - Lifetime
- 1989-09-15 AT AT89117112T patent/ATE98693T1/de not_active IP Right Cessation
- 1989-09-16 HU HU895573A patent/HUT53937A/hu unknown
-
1990
- 1990-05-14 FI FI902391A patent/FI902391A0/fi not_active IP Right Cessation
- 1990-05-15 DK DK120290A patent/DK120290A/da not_active Application Discontinuation
- 1990-05-15 NO NO90902176A patent/NO902176L/no unknown
- 1990-05-16 KR KR1019900701019A patent/KR900702027A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE68911461D1 (de) | 1994-01-27 |
| WO1990002800A1 (en) | 1990-03-22 |
| EP0363675A1 (en) | 1990-04-18 |
| NZ230621A (en) | 1992-06-25 |
| EP0396664A1 (en) | 1990-11-14 |
| ATE98693T1 (de) | 1994-01-15 |
| NO902176L (no) | 1990-07-13 |
| DK120290A (da) | 1990-07-16 |
| MY104910A (en) | 1994-06-30 |
| HU895573D0 (en) | 1990-11-28 |
| YU179489A (en) | 1991-10-31 |
| FI902391A0 (fi) | 1990-05-14 |
| CA1340834C (en) | 1999-11-30 |
| IL91615A0 (en) | 1990-04-29 |
| AU4317189A (en) | 1990-04-02 |
| DE68911461T2 (de) | 1994-05-19 |
| GB8821795D0 (en) | 1988-10-19 |
| PT91719B (pt) | 1995-05-31 |
| AU620925B2 (en) | 1992-02-27 |
| EP0363675B1 (en) | 1993-12-15 |
| PT91719A (pt) | 1990-03-30 |
| DK120290D0 (da) | 1990-05-15 |
| JPH03501855A (ja) | 1991-04-25 |
| JP2888575B2 (ja) | 1999-05-10 |
| KR900702027A (ko) | 1990-12-05 |
| ES2061855T3 (es) | 1994-12-16 |
| NO902176D0 (no) | 1990-05-15 |
| HUT53937A (en) | 1990-12-28 |
| CN1041181A (zh) | 1990-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA897020B (en) | Derivatives of human/bovine basic fibroblast growth factor | |
| PL322945A1 (en) | Novel protein and method of obtaining same | |
| GR3020517T3 (en) | Human erythropoietin muteins, their production and their use | |
| EP0458959A4 (en) | Novel platelet-derived growth factor b chain analogs and method for homogeneous production thereof | |
| SG49097A1 (en) | Nucleotide sequences coding for a protein with urease activity | |
| EP0237966A3 (en) | Human basic fibroblast growth factor | |
| GB8727045D0 (en) | Immunoglobulin e competitor | |
| IL92669A (en) | TGF beta 1/beta 2: a chimeric transforming growth factor-beta | |
| DK38889A (da) | Onkogen-indkodet polypeptid med vaekstfaktoraktivitet | |
| EP0276778A3 (en) | High level expression in e. coli of soluble mature hil-1beta and derivatives with altered biological activity | |
| EP0315118A3 (en) | Dna coding for endothelin and use thereof | |
| HUT62327A (en) | Process for producing somatotropins modified in their alfa-helix 1 region and their combination with other mutants | |
| HUT44609A (en) | Process for preparing new polypeptides | |
| ATE131175T1 (de) | Protein mit fibroblasten-wachstumsfaktor- rezeptoraktivität. | |
| IL85759A0 (en) | The cloning of malaria-specific dna sequences,isolation of the gene for the 140 kd protein | |
| DE68927009D1 (de) | EXPRESSION UND PROZESSIERUNG VON ACETYLIERTEN FGFs IN HEFEN | |
| AU637589B2 (en) | Ancrod proteins, their production and use | |
| IL78278A0 (en) | Process for the production of polypeptides,dna sequence encoding desired polypeptide human somatomedin c polypeptide and recombinant dna molecules | |
| DE59106997D1 (de) | Ancrod ähnliche proteine, ihre herstellung und verwendung. | |
| Bergonzoni et al. | Deletion mutant of basic fibroblast growth factor and production thereof |